Cargando…

Added value of cardiovascular calcifications for prediction of recurrent cardiovascular events and cardiovascular interventions in patients with established cardiovascular disease

The purpose is to investigate the added prognostic value of coronary artery calcium (CAC), thoracic aortic calcium (TAC), and heart valve calcium scores for prediction of a combined endpoint of recurrent major cardiovascular events and cardiovascular interventions (MACE +) in patients with establish...

Descripción completa

Detalles Bibliográficos
Autores principales:	van ’t Klooster, Cilie C., van der Graaf, Yolanda, Nathoe, Hendrik M., Bots, Michiel L., de Borst, Gert J., Visseren, Frank L. J., Leiner, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255266/ https://www.ncbi.nlm.nih.gov/pubmed/33580447 http://dx.doi.org/10.1007/s10554-021-02164-9

Ejemplares similares

Multifocal cardiovascular calcification in patients with established cardiovascular disease; prevalence, risk factors, and relation with recurrent cardiovascular disease
por: van 't Klooster, Cilie C., et al.
Publicado: (2020)

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease
por: Bots, Sophie H., et al.
Publicado: (2016)

The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease
por: Groenland, Eline H., et al.
Publicado: (2022)

Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular Disease
por: van ’t Klooster, Cilie C., et al.
Publicado: (2020)

External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular disease
por: Smidt, Lisanne C. A., et al.
Publicado: (2021)

The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study
por: van’t Klooster, Cilie C, et al.
Publicado: (2019)

Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: a cohort study
por: Selvarajah, Sharmini, et al.
Publicado: (2011)

Low-Density Lipoprotein Cholesterol Target Attainment in Patients With Established Cardiovascular Disease: Analysis of Routine Care Data
por: Groenhof, T Katrien J, et al.
Publicado: (2020)

The association of incidentally detected heart valve calcification with future cardiovascular events
por: Gondrie, Martijn J. A., et al.
Publicado: (2010)

Intimal and medial calcification in relation to cardiovascular risk factors
por: Zwakenberg, Sabine R., et al.
Publicado: (2020)

Risk Factor Clusters and Cardiovascular Disease in High-Risk Patients: The UCC-SMART Study
por: Holthuis, Emily I., et al.
Publicado: (2021)

Impact of Cardiovascular Calcifications on the Detrimental Effect of Continued Smoking on Cardiovascular Risk in Male Lung Cancer Screening Participants
por: Jairam, Pushpa M., et al.
Publicado: (2013)

Cohort profile: the Utrecht Cardiovascular Cohort–Second Manifestations of Arterial Disease (UCC-SMART) Study–an ongoing prospective cohort study of patients at high cardiovascular risk in the Netherlands
por: Castelijns, Maria C, et al.
Publicado: (2023)

Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill
por: Lafeber, M., et al.
Publicado: (2016)

Imaging Cardiovascular Calcification
por: Wang, Ying, et al.
Publicado: (2018)

Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART‐REACH Model
por: Kaasenbrood, Lotte, et al.
Publicado: (2018)

Biomolecules Orchestrating Cardiovascular Calcification
por: Tintut, Yin, et al.
Publicado: (2021)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
por: de Jong, Marit, et al.
Publicado: (2017)

Evaluating a cardiovascular disease risk management care continuum within a learning healthcare system: a prospective cohort study
por: Groenhof, T Katrien J, et al.
Publicado: (2020)

Physical exercise volume, type, and intensity and risk of all-cause mortality and cardiovascular events in patients with cardiovascular disease: a mediation analysis
por: Bonekamp, Nadia E, et al.
Publicado: (2023)

Genetic Determinants of Serum Calcification Propensity and Cardiovascular Outcomes in the General Population
por: de Haan, Amber, et al.
Publicado: (2022)

The effect of computerized decision support systems on cardiovascular risk factors: a systematic review and meta-analysis
por: Groenhof, T. Katrien J., et al.
Publicado: (2019)

Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care
por: de Beus, Esther, et al.
Publicado: (2017)

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm
por: Hageman, Steven H J, et al.
Publicado: (2022)

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
por: Sharif, Shahnam, et al.
Publicado: (2021)

A computerised decision support system for cardiovascular risk management ‘live’ in the electronic health record environment: development, validation and implementation—the Utrecht Cardiovascular Cohort Initiative
por: Groenhof, T. K. J., et al.
Publicado: (2019)

Lipoproteins in Cardiovascular Calcification: Potential Targets and Challenges
por: Tintut, Yin, et al.
Publicado: (2018)

Rationale and design of the Measuring Athlete’s Risk of Cardiovascular events (MARC) study: The role of coronary CT in the cardiovascular evaluation of middle-aged sportsmen
por: Braber, T. L., et al.
Publicado: (2014)

Optimizing cardiovascular risk assessment and registration in a developing cardiovascular learning health care system: Women benefit most
por: Groenhof, T. Katrien J., et al.
Publicado: (2023)

Cardiovascular risk reduction with integrated care: results of 8 years follow up
por: Smits, Geert H. J. M., et al.
Publicado: (2023)

Integrated cardiovascular risk management programme versus usual care in patients at high cardiovascular risk: an observational study in general practice
por: Marchal, Suzanne, et al.
Publicado: (2021)

Notch Signaling in Cardiovascular Disease and Calcification
por: Rusanescu, Gabriel, et al.
Publicado: (2008)

Cell Phenotype Transitions in Cardiovascular Calcification
por: Hortells, Luis, et al.
Publicado: (2018)

Extracellular Vesicles As Mediators of Cardiovascular Calcification
por: Bakhshian Nik, Amirala, et al.
Publicado: (2017)

Emerging roles of fibroblasts in cardiovascular calcification
por: Li, Wudi, et al.
Publicado: (2020)

Estimated cardiovascular benefits of bempedoic acid in patients with established cardiovascular disease
por: Gunn, Laura H., et al.
Publicado: (2022)

The challenge of choosing in cardiovascular risk management
por: Hoogeveen, R. M., et al.
Publicado: (2021)

Ideal Cardiovascular Health in Young Adults With Established Cardiovascular Diseases
por: Leopold, Jane A., et al.
Publicado: (2022)

No psychological distress in sportsmen aged 45 years and older after cardiovascular screening, including cardiac CT: The Measuring Athlete’s Risk of Cardiovascular events (MARC) study
por: Schurink, M. M., et al.
Publicado: (2017)

Stepwise implementation of a cardiovascular risk management care program in primary care
por: Smits, Geert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b9apu2r6sarov7h8om3hgicekk